0

Close
 
Upcoming Allied Market Research
2023
Whole Exome Sequencing Market

Whole Exome Sequencing Market

by Product (Systems, Kits, Services), by Technology (Sequencing by Synthesis, ION Semiconductor Sequencing, Other Technologies), by Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, Others) and by End User (Hospitals and Clinics, Research Centers, Pharmaceutical and Biotechnology Companies, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech
Report Code: A04049
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Whole Exome Sequencing Market

Request Now !

Exome sequencing is a technique for sequencing all of the exome and protein-coding genes in a genome. This technique includes selection of the subset of DNA that encodes proteins or exons, followed by sequencing of the exonic DNA using high-throughput DNA sequencing methods. Exome sequencing is used to identify genetic variants responsible for diseases such as Miller Syndrome and Alzheimers disease.

The global whole exome sequencing market is driven by increase in number of R&D activities to fulfill new scientific applications, high adoption of advanced technologies, rise in awareness about whole exome sequencing technology, and high demand for diagnosis of rare diseases. However, lack of skilled professionals and ethical & legal issues associated with these techniques restrain the market growth. Furthermore, the high demand for personalized medicine and development of new innovative products by key players provide numerous opportunities for market expansion in the near future.

The whole exome sequencing market is segmented on the basis of product, technology, application, end user, and region. Based on product, it is divided into systems, kits, and services. Systems is further divided into Hiseq Series, Miseq, and ION torrent platforms. Hiseq series is further bifurcated into Hiseq 2500 and Hiseq 1500. ION torrent platforms is sub-divided into ION PGM and ION Proton. Kits are further sub-segmented into DNA fragmentation, end repair, A-Tailing, size selection kits, library preparation kits, and target enrichment kits. The services segment is divided into sequencing services and data analysis (bioinformatics) services. Based on technology, the market is categorized into sequencing by synthesis, ION semiconductor sequencing, and others. The application segment includes diagnostics, drug discovery and development, personalized medicine, agriculture and animal research, and others. Diagnostics application segment is further sub-segmented into cancer diagnostics, monogenic (Mendelian) disorders, monogenic types of diabetes, and others. On the basis of end user, the market is classified into hospitals, clinics, research centers, academic & government institutes, pharmaceutical & biotechnology companies, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the market include Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, F. Hoffmann-La Roche AG, Eurofins Scientific Group, GENEWIZ, Inc., Knome, Inc., Macrogen, Inc., Ambry Genetics Corp., and Beijing Genomics Institute.

Key Benefits

  • The study provides an in-depth analysis of the global whole exome sequencing market with current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
  • Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

 Whole Exome Sequencing Market Report Highlights

Aspects Details
By Product
  • Systems
    • Hiseq Series
      • Hiseq 2500
      • Hiseq 1500
    • Miseq
    • ION Torrent Platforms
      • ION PGM
      • ION Proton
  • Kits
    • DNA Fragmentation, End Repair, A-Tailing, and Size Selection Kits
    • Library Preparation Kits
    • Target Enrichment Kits
  • Services
    • Sequencing Services
    • Data Analysis Services
    • Others
By Technology
  • Sequencing by Synthesis
  • ION Semiconductor Sequencing
  • Other Technologies
    • Sequencing by Ligation
    • Pyrosequencing
By Application
  • Diagnostics
    • Cancer Diagnostics
    • Monogenic Disorders
    • Monogenic Types of Diabetes
    • Others
  • Drug Discovery and Development
  • Personalized Medicine
  • Agriculture and Animal Research
  • Others
By End User
  • Hospitals and Clinics
  • Research Centers
  • Pharmaceutical and Biotechnology Companies
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Agilent Technologies, GENEWIZ, Inc, Illumina, Inc., Thermo Fisher Scientific, Inc., Beijing Genomics Institute, Eurofins Scientific Group, Ambry Genetics Corp., Knome, Inc., Macrogen, Inc., F. Hoffmann La Roche AG
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Systems

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Hiseq Series

        • 4.2.4.1. Market Size and Forecast

        • 4.2.4.2. Hiseq 2500

          • 4.2.4.2.1. Market Size and Forecast

        • 4.2.4.2. Hiseq 1500

          • 4.2.4.2.1. Market Size and Forecast

      • 4.2.4. Miseq

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. ION Torrent Platforms

        • 4.2.4.1. Market Size and Forecast

        • 4.2.4.2. ION PGM

          • 4.2.4.2.1. Market Size and Forecast

        • 4.2.4.2. ION Proton

          • 4.2.4.2.1. Market Size and Forecast

    • 4.3. Kits

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. DNA Fragmentation, End Repair, A-Tailing, and Size Selection Kits

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Library Preparation Kits

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Target Enrichment Kits

        • 4.3.4.1. Market Size and Forecast

    • 4.4. Services

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

      • 4.4.4. Sequencing Services

        • 4.4.4.1. Market Size and Forecast

      • 4.4.4. Data Analysis Services

        • 4.4.4.1. Market Size and Forecast

      • 4.4.4. Others

        • 4.4.4.1. Market Size and Forecast

  • CHAPTER 5: WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Technology

    • 5.2. Sequencing By Synthesis

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. ION Semiconductor Sequencing

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Other Technologies

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

      • 5.4.4. Sequencing by Ligation

        • 5.4.4.1. Market Size and Forecast

      • 5.4.4. Pyrosequencing

        • 5.4.4.1. Market Size and Forecast

  • CHAPTER 6: WHOLE EXOME SEQUENCING MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. Diagnostics

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

      • 6.2.4. Cancer Diagnostics

        • 6.2.4.1. Market Size and Forecast

      • 6.2.4. Monogenic Disorders

        • 6.2.4.1. Market Size and Forecast

      • 6.2.4. Monogenic Types of Diabetes

        • 6.2.4.1. Market Size and Forecast

      • 6.2.4. Others

        • 6.2.4.1. Market Size and Forecast

    • 6.3. Drug Discovery And Development

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Personalized Medicine

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Agriculture And Animal Research

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Others

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

  • CHAPTER 7: WHOLE EXOME SEQUENCING MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Hospitals And Clinics

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Research Centers

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Pharmaceutical And Biotechnology Companies

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Others

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

  • CHAPTER 8: WHOLE EXOME SEQUENCING MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Product

      • 8.2.3. Market Size and Forecast, By Technology

      • 8.2.4. Market Size and Forecast, By Application

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Whole Exome Sequencing Market

        • 8.2.7.1. Market Size and Forecast, By Product
        • 8.2.7.2. Market Size and Forecast, By Technology
        • 8.2.7.3. Market Size and Forecast, By Application
        • 8.2.7.4. Market Size and Forecast, By End User

      • 8.2.8. Canada Whole Exome Sequencing Market

        • 8.2.8.1. Market Size and Forecast, By Product
        • 8.2.8.2. Market Size and Forecast, By Technology
        • 8.2.8.3. Market Size and Forecast, By Application
        • 8.2.8.4. Market Size and Forecast, By End User

      • 8.2.9. Mexico Whole Exome Sequencing Market

        • 8.2.9.1. Market Size and Forecast, By Product
        • 8.2.9.2. Market Size and Forecast, By Technology
        • 8.2.9.3. Market Size and Forecast, By Application
        • 8.2.9.4. Market Size and Forecast, By End User

    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Product

      • 8.3.3. Market Size and Forecast, By Technology

      • 8.3.4. Market Size and Forecast, By Application

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Whole Exome Sequencing Market

        • 8.3.7.1. Market Size and Forecast, By Product
        • 8.3.7.2. Market Size and Forecast, By Technology
        • 8.3.7.3. Market Size and Forecast, By Application
        • 8.3.7.4. Market Size and Forecast, By End User

      • 8.3.8. Germany Whole Exome Sequencing Market

        • 8.3.8.1. Market Size and Forecast, By Product
        • 8.3.8.2. Market Size and Forecast, By Technology
        • 8.3.8.3. Market Size and Forecast, By Application
        • 8.3.8.4. Market Size and Forecast, By End User

      • 8.3.9. Italy Whole Exome Sequencing Market

        • 8.3.9.1. Market Size and Forecast, By Product
        • 8.3.9.2. Market Size and Forecast, By Technology
        • 8.3.9.3. Market Size and Forecast, By Application
        • 8.3.9.4. Market Size and Forecast, By End User

      • 8.3.10. Spain Whole Exome Sequencing Market

        • 8.3.10.1. Market Size and Forecast, By Product
        • 8.3.10.2. Market Size and Forecast, By Technology
        • 8.3.10.3. Market Size and Forecast, By Application
        • 8.3.10.4. Market Size and Forecast, By End User

      • 8.3.11. UK Whole Exome Sequencing Market

        • 8.3.11.1. Market Size and Forecast, By Product
        • 8.3.11.2. Market Size and Forecast, By Technology
        • 8.3.11.3. Market Size and Forecast, By Application
        • 8.3.11.4. Market Size and Forecast, By End User

      • 8.3.12. Russia Whole Exome Sequencing Market

        • 8.3.12.1. Market Size and Forecast, By Product
        • 8.3.12.2. Market Size and Forecast, By Technology
        • 8.3.12.3. Market Size and Forecast, By Application
        • 8.3.12.4. Market Size and Forecast, By End User

      • 8.3.13. Rest Of Europe Whole Exome Sequencing Market

        • 8.3.13.1. Market Size and Forecast, By Product
        • 8.3.13.2. Market Size and Forecast, By Technology
        • 8.3.13.3. Market Size and Forecast, By Application
        • 8.3.13.4. Market Size and Forecast, By End User

    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Product

      • 8.4.3. Market Size and Forecast, By Technology

      • 8.4.4. Market Size and Forecast, By Application

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Whole Exome Sequencing Market

        • 8.4.7.1. Market Size and Forecast, By Product
        • 8.4.7.2. Market Size and Forecast, By Technology
        • 8.4.7.3. Market Size and Forecast, By Application
        • 8.4.7.4. Market Size and Forecast, By End User

      • 8.4.8. Japan Whole Exome Sequencing Market

        • 8.4.8.1. Market Size and Forecast, By Product
        • 8.4.8.2. Market Size and Forecast, By Technology
        • 8.4.8.3. Market Size and Forecast, By Application
        • 8.4.8.4. Market Size and Forecast, By End User

      • 8.4.9. India Whole Exome Sequencing Market

        • 8.4.9.1. Market Size and Forecast, By Product
        • 8.4.9.2. Market Size and Forecast, By Technology
        • 8.4.9.3. Market Size and Forecast, By Application
        • 8.4.9.4. Market Size and Forecast, By End User

      • 8.4.10. South Korea Whole Exome Sequencing Market

        • 8.4.10.1. Market Size and Forecast, By Product
        • 8.4.10.2. Market Size and Forecast, By Technology
        • 8.4.10.3. Market Size and Forecast, By Application
        • 8.4.10.4. Market Size and Forecast, By End User

      • 8.4.11. Australia Whole Exome Sequencing Market

        • 8.4.11.1. Market Size and Forecast, By Product
        • 8.4.11.2. Market Size and Forecast, By Technology
        • 8.4.11.3. Market Size and Forecast, By Application
        • 8.4.11.4. Market Size and Forecast, By End User

      • 8.4.12. Thailand Whole Exome Sequencing Market

        • 8.4.12.1. Market Size and Forecast, By Product
        • 8.4.12.2. Market Size and Forecast, By Technology
        • 8.4.12.3. Market Size and Forecast, By Application
        • 8.4.12.4. Market Size and Forecast, By End User

      • 8.4.13. Malaysia Whole Exome Sequencing Market

        • 8.4.13.1. Market Size and Forecast, By Product
        • 8.4.13.2. Market Size and Forecast, By Technology
        • 8.4.13.3. Market Size and Forecast, By Application
        • 8.4.13.4. Market Size and Forecast, By End User

      • 8.4.14. Indonesia Whole Exome Sequencing Market

        • 8.4.14.1. Market Size and Forecast, By Product
        • 8.4.14.2. Market Size and Forecast, By Technology
        • 8.4.14.3. Market Size and Forecast, By Application
        • 8.4.14.4. Market Size and Forecast, By End User

      • 8.4.15. Rest of Asia Pacific Whole Exome Sequencing Market

        • 8.4.15.1. Market Size and Forecast, By Product
        • 8.4.15.2. Market Size and Forecast, By Technology
        • 8.4.15.3. Market Size and Forecast, By Application
        • 8.4.15.4. Market Size and Forecast, By End User

    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Product

      • 8.5.3. Market Size and Forecast, By Technology

      • 8.5.4. Market Size and Forecast, By Application

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Whole Exome Sequencing Market

        • 8.5.7.1. Market Size and Forecast, By Product
        • 8.5.7.2. Market Size and Forecast, By Technology
        • 8.5.7.3. Market Size and Forecast, By Application
        • 8.5.7.4. Market Size and Forecast, By End User

      • 8.5.8. South Africa Whole Exome Sequencing Market

        • 8.5.8.1. Market Size and Forecast, By Product
        • 8.5.8.2. Market Size and Forecast, By Technology
        • 8.5.8.3. Market Size and Forecast, By Application
        • 8.5.8.4. Market Size and Forecast, By End User

      • 8.5.9. Saudi Arabia Whole Exome Sequencing Market

        • 8.5.9.1. Market Size and Forecast, By Product
        • 8.5.9.2. Market Size and Forecast, By Technology
        • 8.5.9.3. Market Size and Forecast, By Application
        • 8.5.9.4. Market Size and Forecast, By End User

      • 8.5.10. UAE Whole Exome Sequencing Market

        • 8.5.10.1. Market Size and Forecast, By Product
        • 8.5.10.2. Market Size and Forecast, By Technology
        • 8.5.10.3. Market Size and Forecast, By Application
        • 8.5.10.4. Market Size and Forecast, By End User

      • 8.5.11. Argentina Whole Exome Sequencing Market

        • 8.5.11.1. Market Size and Forecast, By Product
        • 8.5.11.2. Market Size and Forecast, By Technology
        • 8.5.11.3. Market Size and Forecast, By Application
        • 8.5.11.4. Market Size and Forecast, By End User

      • 8.5.12. Rest of LAMEA Whole Exome Sequencing Market

        • 8.5.12.1. Market Size and Forecast, By Product
        • 8.5.12.2. Market Size and Forecast, By Technology
        • 8.5.12.3. Market Size and Forecast, By Application
        • 8.5.12.4. Market Size and Forecast, By End User

  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Illumina, Inc.

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Thermo Fisher Scientific, Inc.

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Agilent Technologies

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. F. Hoffmann La Roche AG

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. Eurofins Scientific Group

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. GENEWIZ, Inc

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Knome, Inc.

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Macrogen, Inc.

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Ambry Genetics Corp.

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. Beijing Genomics Institute

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL WHOLE EXOME SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR KITS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL WHOLE EXOME SEQUENCING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL WHOLE EXOME SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR RESEARCH CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL WHOLE EXOME SEQUENCING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL WHOLE EXOME SEQUENCING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA WHOLE EXOME SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. U.S. WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. U.S. WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 28. U.S. WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. U.S. WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. CANADA WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. CANADA WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 32. CANADA WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. CANADA WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 36. MEXICO WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. MEXICO WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE WHOLE EXOME SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 41. EUROPE WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. FRANCE WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. FRANCE WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. FRANCE WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. GERMANY WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 48. GERMANY WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 49. GERMANY WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. ITALY WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 52. ITALY WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 53. ITALY WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. ITALY WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. SPAIN WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. SPAIN WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. SPAIN WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. UK WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. UK WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 61. UK WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. UK WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. RUSSIA WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 64. RUSSIA WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 65. RUSSIA WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. RUSSIA WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. REST OF EUROPE WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. REST OF EUROPE WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 69. REST OF EUROPE WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. REST OF EUROPE WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. ASIA-PACIFIC WHOLE EXOME SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 72. ASIA-PACIFIC WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 73. ASIA-PACIFIC WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 74. ASIA-PACIFIC WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. ASIA-PACIFIC WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. CHINA WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 77. CHINA WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 78. CHINA WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. CHINA WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. JAPAN WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 81. JAPAN WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 82. JAPAN WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. JAPAN WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. INDIA WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 85. INDIA WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 86. INDIA WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 87. INDIA WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH KOREA WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH KOREA WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH KOREA WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH KOREA WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. AUSTRALIA WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 93. AUSTRALIA WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 94. AUSTRALIA WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 95. AUSTRALIA WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. THAILAND WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 97. THAILAND WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 98. THAILAND WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 99. THAILAND WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. MALAYSIA WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 101. MALAYSIA WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 102. MALAYSIA WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 103. MALAYSIA WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. INDONESIA WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 105. INDONESIA WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 106. INDONESIA WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 107. INDONESIA WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. REST OF ASIA PACIFIC WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 109. REST OF ASIA PACIFIC WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 110. REST OF ASIA PACIFIC WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 111. REST OF ASIA PACIFIC WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 112. LAMEA WHOLE EXOME SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 113. LAMEA WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 114. LAMEA WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 115. LAMEA WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 116. LAMEA WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 117. BRAZIL WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 118. BRAZIL WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 119. BRAZIL WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 120. BRAZIL WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 121. SOUTH AFRICA WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 122. SOUTH AFRICA WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 123. SOUTH AFRICA WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 124. SOUTH AFRICA WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 125. SAUDI ARABIA WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 126. SAUDI ARABIA WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 127. SAUDI ARABIA WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 128. SAUDI ARABIA WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 129. UAE WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 130. UAE WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 131. UAE WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 132. UAE WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 133. ARGENTINA WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 134. ARGENTINA WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 135. ARGENTINA WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 136. ARGENTINA WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 137. REST OF LAMEA WHOLE EXOME SEQUENCING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 138. REST OF LAMEA WHOLE EXOME SEQUENCING, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 139. REST OF LAMEA WHOLE EXOME SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 140. REST OF LAMEA WHOLE EXOME SEQUENCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 141. ILLUMINA, INC.: KEY EXECUTIVES
  • TABLE 142. ILLUMINA, INC.: COMPANY SNAPSHOT
  • TABLE 143. ILLUMINA, INC.: OPERATING SEGMENTS
  • TABLE 144. ILLUMINA, INC.: PRODUCT PORTFOLIO
  • TABLE 145. ILLUMINA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 146. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
  • TABLE 147. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • TABLE 148. THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
  • TABLE 149. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
  • TABLE 150. THERMO FISHER SCIENTIFIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 151. AGILENT TECHNOLOGIES: KEY EXECUTIVES
  • TABLE 152. AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
  • TABLE 153. AGILENT TECHNOLOGIES: OPERATING SEGMENTS
  • TABLE 154. AGILENT TECHNOLOGIES: PRODUCT PORTFOLIO
  • TABLE 155. AGILENT TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 156. F. HOFFMANN LA ROCHE AG: KEY EXECUTIVES
  • TABLE 157. F. HOFFMANN LA ROCHE AG: COMPANY SNAPSHOT
  • TABLE 158. F. HOFFMANN LA ROCHE AG: OPERATING SEGMENTS
  • TABLE 159. F. HOFFMANN LA ROCHE AG: PRODUCT PORTFOLIO
  • TABLE 160. F. HOFFMANN LA ROCHE AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 161. EUROFINS SCIENTIFIC GROUP: KEY EXECUTIVES
  • TABLE 162. EUROFINS SCIENTIFIC GROUP: COMPANY SNAPSHOT
  • TABLE 163. EUROFINS SCIENTIFIC GROUP: OPERATING SEGMENTS
  • TABLE 164. EUROFINS SCIENTIFIC GROUP: PRODUCT PORTFOLIO
  • TABLE 165. EUROFINS SCIENTIFIC GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 166. GENEWIZ, INC: KEY EXECUTIVES
  • TABLE 167. GENEWIZ, INC: COMPANY SNAPSHOT
  • TABLE 168. GENEWIZ, INC: OPERATING SEGMENTS
  • TABLE 169. GENEWIZ, INC: PRODUCT PORTFOLIO
  • TABLE 170. GENEWIZ, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 171. KNOME, INC.: KEY EXECUTIVES
  • TABLE 172. KNOME, INC.: COMPANY SNAPSHOT
  • TABLE 173. KNOME, INC.: OPERATING SEGMENTS
  • TABLE 174. KNOME, INC.: PRODUCT PORTFOLIO
  • TABLE 175. KNOME, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 176. MACROGEN, INC.: KEY EXECUTIVES
  • TABLE 177. MACROGEN, INC.: COMPANY SNAPSHOT
  • TABLE 178. MACROGEN, INC.: OPERATING SEGMENTS
  • TABLE 179. MACROGEN, INC.: PRODUCT PORTFOLIO
  • TABLE 180. MACROGEN, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 181. AMBRY GENETICS CORP.: KEY EXECUTIVES
  • TABLE 182. AMBRY GENETICS CORP.: COMPANY SNAPSHOT
  • TABLE 183. AMBRY GENETICS CORP.: OPERATING SEGMENTS
  • TABLE 184. AMBRY GENETICS CORP.: PRODUCT PORTFOLIO
  • TABLE 185. AMBRY GENETICS CORP.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 186. BEIJING GENOMICS INSTITUTE: KEY EXECUTIVES
  • TABLE 187. BEIJING GENOMICS INSTITUTE: COMPANY SNAPSHOT
  • TABLE 188. BEIJING GENOMICS INSTITUTE: OPERATING SEGMENTS
  • TABLE 189. BEIJING GENOMICS INSTITUTE: PRODUCT PORTFOLIO
  • TABLE 190. BEIJING GENOMICS INSTITUTE: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL WHOLE EXOME SEQUENCING MARKET SEGMENTATION
  • FIGURE 2. GLOBAL WHOLE EXOME SEQUENCING MARKET
  • FIGURE 3. SEGMENTATION WHOLE EXOME SEQUENCING MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN WHOLE EXOME SEQUENCING MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALWHOLE EXOME SEQUENCING MARKET
  • FIGURE 11. WHOLE EXOME SEQUENCING MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. WHOLE EXOME SEQUENCING MARKET FOR SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. WHOLE EXOME SEQUENCING MARKET FOR KITS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. WHOLE EXOME SEQUENCING MARKET FOR SERVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. WHOLE EXOME SEQUENCING MARKET SEGMENTATION, BY BY TECHNOLOGY
  • FIGURE 16. WHOLE EXOME SEQUENCING MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. WHOLE EXOME SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. WHOLE EXOME SEQUENCING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. WHOLE EXOME SEQUENCING MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 20. WHOLE EXOME SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. WHOLE EXOME SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. WHOLE EXOME SEQUENCING MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. WHOLE EXOME SEQUENCING MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. WHOLE EXOME SEQUENCING MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. WHOLE EXOME SEQUENCING MARKET SEGMENTATION, BY BY END USER
  • FIGURE 26. WHOLE EXOME SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. WHOLE EXOME SEQUENCING MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. WHOLE EXOME SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. WHOLE EXOME SEQUENCING MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 31. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 32. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 33. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 34. COMPETITIVE DASHBOARD
  • FIGURE 35. COMPETITIVE HEATMAP: WHOLE EXOME SEQUENCING MARKET
  • FIGURE 36. Top player positioning, 2022
  • FIGURE 37. ILLUMINA, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. ILLUMINA, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. ILLUMINA, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. AGILENT TECHNOLOGIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. AGILENT TECHNOLOGIES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. AGILENT TECHNOLOGIES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. F. HOFFMANN LA ROCHE AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. F. HOFFMANN LA ROCHE AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. F. HOFFMANN LA ROCHE AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. EUROFINS SCIENTIFIC GROUP: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. EUROFINS SCIENTIFIC GROUP: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. EUROFINS SCIENTIFIC GROUP: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. GENEWIZ, INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. GENEWIZ, INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. GENEWIZ, INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. KNOME, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. KNOME, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. KNOME, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 58. MACROGEN, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. MACROGEN, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 60. MACROGEN, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 61. AMBRY GENETICS CORP.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 62. AMBRY GENETICS CORP.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 63. AMBRY GENETICS CORP.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 64. BEIJING GENOMICS INSTITUTE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 65. BEIJING GENOMICS INSTITUTE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 66. BEIJING GENOMICS INSTITUTE: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Whole Exome Sequencing Market

Start reading.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers